Bruce Jackson
Stock Analyst at Benchmark Co.
(0.07)
# 4,414
Out of 4,457 analysts
297
Total ratings
35.8%
Success rate
-10.8%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED MiniMed Group | Maintained: Buy | $20 | $14.88 | +34.41% | 2 | Jun 3, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $15 → $18 | $7.70 | +133.77% | 10 | Jun 2, 2026 | |
| HUMA Humacyte | Maintained: Buy | $1 → $2 | $0.7989 | +150.34% | 23 | Jun 1, 2026 | |
| BFRI Biofrontera | Maintained: Buy | $3 | $1.02 | +194.12% | 20 | May 19, 2026 | |
| PODD Insulet | Initiated Coverage: Buy | $250 | $157.74 | +58.49% | 1 | May 12, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $77 | $69.98 | +10.03% | 1 | May 11, 2026 | |
| TNDM Tandem Diabetes Care | Initiated Coverage: Hold | n/a | $15.83 | - | 1 | May 11, 2026 | |
| NEO NeoGenomics | Upgraded: Buy | $11 | $14.25 | -22.81% | 23 | Apr 29, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $145 → $120 | $92.71 | +29.44% | 4 | Apr 17, 2026 | |
| CV CapsoVision | Maintained: Buy | $14 → $10 | $7.58 | +31.93% | 5 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $20 | $2.88 | +594.44% | 11 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $6 | $6.17 | -2.76% | 18 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $187 → $217 | $154.65 | +40.32% | 21 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 | $6.34 | +389.34% | 18 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.25 → $1 | $0.3203 | +212.21% | 6 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.7126 | - | 20 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.42 | - | 14 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $140 | $0.65 | +21,438.46% | 4 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.88 | n/a | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $0.9621 | n/a | 6 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.35 → $2 | $2.08 | n/a | 6 | Jun 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $24 | $0.4465 | n/a | 4 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1 | $0.327 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $0.4 | $0.000001 | n/a | 6 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $960 → $240 | $0.0001 | n/a | 8 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $29.33 | n/a | 15 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $5 | $5.42 | n/a | 13 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.00 | n/a | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $4 | $2.75 | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.40 | n/a | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.15 | n/a | 3 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $1.23 | n/a | 1 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $0.4355 | n/a | 3 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $38 | $44.72 | n/a | 5 | Mar 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.91 | n/a | 5 | Feb 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.35 | n/a | 1 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 → $92 | $18.74 | n/a | 2 | Oct 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $46 | $80.93 | n/a | 2 | Nov 21, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $43.48 | n/a | 2 | Mar 2, 2012 |
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $20
Current: $14.88
Upside: +34.41%
Unicycive Therapeutics
Jun 2, 2026
Maintained: Buy
Price Target: $15 → $18
Current: $7.70
Upside: +133.77%
Humacyte
Jun 1, 2026
Maintained: Buy
Price Target: $1 → $2
Current: $0.7989
Upside: +150.34%
Biofrontera
May 19, 2026
Maintained: Buy
Price Target: $3
Current: $1.02
Upside: +194.12%
Insulet
May 12, 2026
Initiated Coverage: Buy
Price Target: $250
Current: $157.74
Upside: +58.49%
DexCom
May 11, 2026
Initiated Coverage: Buy
Price Target: $77
Current: $69.98
Upside: +10.03%
Tandem Diabetes Care
May 11, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $15.83
Upside: -
NeoGenomics
Apr 29, 2026
Upgraded: Buy
Price Target: $11
Current: $14.25
Upside: -22.81%
Abbott Laboratories
Apr 17, 2026
Maintained: Buy
Price Target: $145 → $120
Current: $92.71
Upside: +29.44%
CapsoVision
Mar 27, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $7.58
Upside: +31.93%
Mar 20, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $2.88
Upside: +594.44%
Mar 16, 2026
Maintained: Buy
Price Target: $20 → $6
Current: $6.17
Upside: -2.76%
Mar 3, 2026
Maintained: Buy
Price Target: $187 → $217
Current: $154.65
Upside: +40.32%
Dec 3, 2025
Reiterated: Buy
Price Target: $31
Current: $6.34
Upside: +389.34%
Nov 20, 2025
Maintained: Buy
Price Target: $1.25 → $1
Current: $0.3203
Upside: +212.21%
Nov 7, 2025
Maintained: Hold
Price Target: n/a
Current: $0.7126
Upside: -
Sep 15, 2025
Maintained: Hold
Price Target: n/a
Current: $1.42
Upside: -
Sep 15, 2025
Maintained: Buy
Price Target: $280 → $140
Current: $0.65
Upside: +21,438.46%
Nov 26, 2024
Reiterated: Buy
Price Target: $8
Current: $4.88
Upside: n/a
Oct 11, 2024
Reiterated: Buy
Price Target: $5 → $3
Current: $0.9621
Upside: n/a
Jun 6, 2024
Maintained: Buy
Price Target: $1.35 → $2
Current: $2.08
Upside: n/a
Apr 15, 2024
Maintained: Buy
Price Target: $40 → $24
Current: $0.4465
Upside: n/a
Apr 8, 2024
Initiated Coverage: Buy
Price Target: $1
Current: $0.327
Upside: n/a
Mar 22, 2024
Maintained: Buy
Price Target: $4 → $0.4
Current: $0.000001
Upside: n/a
Sep 21, 2023
Maintained: Buy
Price Target: $960 → $240
Current: $0.0001
Upside: n/a
Sep 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $29.33
Upside: n/a
Aug 24, 2023
Maintained: Buy
Price Target: $9 → $5
Current: $5.42
Upside: n/a
Jul 21, 2023
Initiated Coverage: Buy
Price Target: $5
Current: $1.00
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $8 → $4
Current: $2.75
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $6
Current: $0.40
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: $8
Current: $4.15
Upside: n/a
Jul 20, 2018
Initiated Coverage: Buy
Price Target: $27
Current: $1.23
Upside: n/a
Apr 5, 2018
Reiterated: Buy
Price Target: $42
Current: $0.4355
Upside: n/a
Mar 2, 2018
Reiterated: Buy
Price Target: $26 → $38
Current: $44.72
Upside: n/a
Feb 26, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.91
Upside: n/a
Feb 2, 2018
Initiated Coverage: Buy
Price Target: $8
Current: $1.35
Upside: n/a
Oct 28, 2016
Upgraded: Buy
Price Target: $40 → $92
Current: $18.74
Upside: n/a
Nov 21, 2012
Maintained: Hold
Price Target: $46
Current: $80.93
Upside: n/a
Mar 2, 2012
Initiated Coverage: Buy
Price Target: n/a
Current: $43.48
Upside: n/a